Fri.Nov 12, 2021

article thumbnail

J&J, world's largest drugmaker, plans to split in two

Bio Pharma Dive

The industry giant and mainstay of corporate America will separate its consumer health business from its drug and medical device units, which will retain the J&J brand.

Branding 344
article thumbnail

Pharma needs to move to digital NOW

World of DTC Marketing

SUMMARY: Today, more physicians and patients rely on the Internet to answer their questions about emerging treatments, including prescription drugs. If there is one industry that needs to think more about digital, it’s pharma. The reliance on agencies still is a building block, but who on the brand team is the person to ensure you maximize your digital strategy?

Branding 180
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cortexyme plans path forward for Alzheimer's drug that failed study

Bio Pharma Dive

Detailed results presented Thursday show no difference between the biotech's drug and placebo on the study's main measures. But a seeming benefit in a subgroup of patients convinced the company to plan another trial.

Drugs 316
article thumbnail

AI tool may help doctors select best drugs for COVID patients

pharmaphorum

Researchers in the US have developed an artificial intelligence-based tool that is able to predict COVID-19 symptoms and suggest which FDA-approved drugs might be used to treat patients. The MOATAI-VIR algorithm, developed by scientists at Emory University and Georgia Tech, was put through its paces in a study that showed it was able to predict 24 out of 26 clinical manifestations of COVID-19, including acute respiratory distress, blood clotting issues, cytokine storms, brain fog, and loss of sm

Doctors 135
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

New COVID-19 vaccines could target replication proteins

Pharma Times

Researchers have said that next generation vaccines for COVID-19 should aim to induce a response against ‘replication proteins’

Protein 119
article thumbnail

Researchers discover the first instance of living organisms producing elemental carbon

Scienmag

Carbon is the building block of all known life on our planet. The carbon cycle regulates the release and absorption of carbon from a number of natural sources — including the ocean, soil, geochemical processes, and human emissions — to maintain a delicate balance of this crucial element in our world. Credit: Kristin Rose Jutras […].

Research 102

More Trending

article thumbnail

Johnson & Johnson to spin off consumer health business

BioPharma Reporter

Johnson & Johnson today announced its intent to separate its Consumer Health business into a new publicly traded company: allowing J&J to put a sharpened focus on pharmaceuticals and medical devices.

article thumbnail

NICE ‘no’ for BioMarin’s Vimizin

Pharma Times

The draft guidance has been published following an evaluation of new evidence on the use of the treatment

118
118
article thumbnail

Capturing a true picture of wolves in Yellowstone: Reevaluating aspen recovery

Scienmag

It’s an environmental success story that feels like a parable—the reintroduction of wolves in Yellowstone National Park in the mid-1990s triggered a cascade of effects that ultimately restored the ecosystem, including the recovery of aspen trees. But like many stories based on ecological realities, it’s more complex than at first glance—aspen recovery in the park […].

91
article thumbnail

Alleviating CGT bottlenecks: Standards needed to ensure volumes, quality of starting material

BioPharma Reporter

Be the Match BioTherapies (BTMB) says it is critical that resilient cell sourcing infrastructures exist when cell and gene therapies (CGT) surge to market.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Otago researchers discover best way to avoid procrastination

Scienmag

They say procrastination is the thief of time – actually deadlines are. Credit: The University of Otago They say procrastination is the thief of time – actually deadlines are. New research from the University of Otago has found that if you want someone to help you out with something, it is best not to set […].

article thumbnail

New drug combination highly effective in children with leukaemia

Pharma Times

APL is an acute leukaemia, meaning it develops quickly and requires immediate treatment

Drugs 94
article thumbnail

Rice lab details conditions to decontaminate disposable masks

Scienmag

HOUSTON – (Nov. 12, 2021) – Here’s the recipe to decontaminate a disposable facemask: Heat it at 160 degrees Fahrenheit in an oven for five minutes. You can use your own oven. Credit: Faye Yap/Rice University HOUSTON – (Nov. 12, 2021) – Here’s the recipe to decontaminate a disposable facemask: Heat it at 160 degrees […].

90
article thumbnail

Novo Nordisk nears EU approval of obesity drug Wegovy

pharmaphorum

Danish drugmaker Novo Nordisk is hoping to launch its once-weekly injectable treatment for obesity, Wegovy, in the EU next year after getting a green light from the EMA’s human medicines committee. The CHMP recommended marketing authorisation for Wegovy (semaglutide) for chronic weight management in adults with obesity, and also in overweight adult patients with a weight-related risk factor such as high blood pressure, heart disease or type 2 diabetes.

Drugs 59
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

More than half of surveyed crop varieties are under threat of extinction, according to study in India

Scienmag

Crop and varietal diversity are critically important for global food and nutrition security, as well as the livelihoods of millions of people, especially those living in marginal areas. This diversity includes many different crop species and farmer varieties[1], many of which have been cultivated and safeguarded by farmers and indigenous peoples for millennia on their […].

90
article thumbnail

Johnson & Johnson Will Break Itself Up Into Two Companies

NY Times

The 135-year-old company announced plans to divide itself into a consumer products business and a medical company.

article thumbnail

Study: Obesity raises the risk of gum disease by inflating growth of bone-destroying cells

Scienmag

BUFFALO, N.Y. – Chronic inflammation caused by obesity may trigger the development of cells that break down bone tissue, including the bone that holds teeth in place, according to new University at Buffalo research that sought to improve understanding of the connection between obesity and gum disease. Credit: Photo: Keith Kirkwood. BUFFALO, N.Y. – Chronic […].

article thumbnail

Recruitment in Clinical Trials – Part 1: An Overview

Cloudbyz

This article is the first part of a Cloudbyz series of articles about Recruitment & Retention in clinical trials. There are many challenges to recruitment in the field of clinical trials. There are also a number of solutions; some of them new and burgeoning, while others are tried and tested. But before delving into details as deep as the challenges of recruitment & retention in clinical trials, potential resolutions, and the future of recruitment, it is important to see the current recr

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Stress-testing physics at FRIB

Scienmag

It’s strange to think that there are nuclear reactions that physicists classify as gentle. After all, the particle accelerators that let scientists study these reactions are nicknamed “atom smashers,” not “atom coddlers.” Credit: Facility for Rare Isotope Beams It’s strange to think that there are nuclear reactions that physicists classify as gentle.

article thumbnail

New patent for Pfizer drug TALZENNA

Drug Patent Watch

Annual Drug Patent Expirations for TALZENNA Talzenna is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are five patents protecting…. The post New patent for Pfizer drug TALZENNA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

USask chickpea research aims to improve important food source for low- and lower-middle-income countries

Scienmag

SASKATOON – University of Saskatchewan (USask) researchers are part of a global team that used DNA to track the genetic evolution and migration of the chickpea,?offering insights that could lead to more nutritious and adaptable varieties. Credit: Bunyamin Tar’an SASKATOON – University of Saskatchewan (USask) researchers are part of a global team that used DNA to track the genetic evolution and migration of the chickpea,?

DNA 85
article thumbnail

New patent for Gilead Sciences drug BIKTARVY

Drug Patent Watch

Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are ten…. The post New patent for Gilead Sciences drug BIKTARVY appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Oncotarget: Nanoparticle T cell engagers for the treatment of acute myeloid leukemia

Scienmag

Oncotarget published “Nanoparticle T cell engagers for the treatment of acute myeloid leukemia” which reported that Acute myeloid leukemia (AML) is the most common type of leukemia and has a 5-year survival rate of 25%. Credit: Correspondence to – Abdel Kareem Azab – kareem.azab@wustl.edu Oncotarget published “Nanoparticle T cell engagers for the treatment of acute myeloid leukemia” which reported […].

83
article thumbnail

New patent expiration for Bayer Hlthcare drug EOVIST

Drug Patent Watch

Annual Drug Patent Expirations for EOVIST Eovist is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There is one patent…. The post New patent expiration for Bayer Hlthcare drug EOVIST appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Salk Institute awards Medal for Research Excellence to neurobiologist and geneticist Cori Bargmann

Scienmag

LA JOLLA—(November 12, 2021) The Salk Institute has awarded neurobiologist and geneticist Cori Bargmann its prestigious Medal for Research Excellence, which recognizes a scientist who has made significant contributions in the area of basic scientific research. Bargmann, who leads the science program at the Chan Zuckerberg Initiative (CZI) and is the Torsten N.

article thumbnail

“It’s the Integrity” – An Intouch Boomerang Talks About What Drew Her Back

Intouch Solutions

Did you know that the boomerang most of us are familiar with — the type used by Australian aborigines for hunting — is not the only kind of boomerang? Yep, apparently, there’s another kind, and it’s been found in parts of Europe — one from Poland, was made from a mammoth’s tusk and is believed to be ~30,000 years old — in Egypt (of course King Tut had a collection), and in California and Arizona!

52
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Oncotarget: High expression of Myosin 1g in pediatric acute lymphoblastic leukemia

Scienmag

Oncotarget published “High expression of Myosin 1g in pediatric acute lymphoblastic leukemia” which reported that class I myosins are molecular motors involved in membrane tension, endocytosis, phagocytosis and cell migration and recently they have been shown important for development and aggressiveness of diverse cancer types, however Myo1g an hematopoietic specific myosin has not been studied in […].

article thumbnail

Culture riding virtual R&D wave, latest funding round enables development of cloud bioreactors

BioPharma Reporter

Culture Biosciences, a company enabling biotech firms to develop and scale manufacturing processes in the cloud, recently announced an $80m Series B round, taking the funds it has raised to date to $100m+.

article thumbnail

The challenge of forest restoration: where to obtain tens of billions of quality seeds

Scienmag

With commitments to restore more than 47.5 million hectares of degraded land and forests by 2030, the Philippines, Indonesia, Malaysia and India hope to become exemplar land custodians. While commitments ending deforestation are critical to obtaining that image – Indonesia is one of the world’s poster children for forest loss – even a full halt […].

article thumbnail

Are Buttered Pop-Tarts a Lasting Trend or a Momentary Fan Favorite?

XTalks

Adding butter to your Pop-Tarts may seem outrageous, but the world has turned this craze into a trend. The company has embraced this movement and morphed it into a new combo. Now, consumers can buy a limited-edition Pop-Tarts x Butter Kit. Buttered Pop-Tarts are a favorite that many cannot stop talking about on social media. So, the company decided to combine the two products and provide consumers with a kit that includes everything they need to enjoy the combo.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.